White Douglas B, Curtis J Randall, Lo Bernard, Luce John M
Division of Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Crit Care Med. 2006 Aug;34(8):2053-9. doi: 10.1097/01.CCM.0000227654.38708.C1.
Many intensive care unit (ICU) physicians have withdrawn life-support from a patient who lacked decision-making capacity and a surrogate decision-maker, yet little is known about the decision-making practices for these patients. We sought to determine how often such patients are admitted to the ICU of a metropolitan hospital and how end-of-life decisions are made for them.
Prospective, observational cohort study.
Consecutive adult patients admitted to the medical ICU of a metropolitan West Coast hospital during a 7-month period in 2003 to 2004.
Attending physicians completed a questionnaire about the decision-making process for each patient for whom they considered limiting life-support who lacked decisional capacity and a legally recognized surrogate decision-maker.
Of the 303 patients admitted during the study period, 49 (16%; 95% confidence interval [CI], 12-21%) lacked decision-making capacity and a surrogate during the entire ICU stay. Compared with all other ICU patients, these patients were more likely to be male (88% vs. 69%; p = .002), white (42% vs. 23%; p = .028), and > or =65 yrs old (29% vs. 13%; p = .007). Physicians considered withholding or withdrawing treatment from 37% (18) of the 49 patients who lacked both decision-making capacity and a surrogate decision-maker. For 56% (10) of these 18 patients, the opinion of another attending physician was obtained; for 33% (6 of 18), the ICU team made the decision independently, and for 11% (2 of 18), the input of the courts or the hospital ethics committee was obtained. Overall, 27% of deaths (13 of 49) during the study period were in incapacitated patients who lacked a surrogate (95% CI, 15-41%).
Sixteen percent of patients admitted to the medical ICU of this hospital lacked both decision-making capacity and a surrogate decision-maker. Decisions to limit life support were generally made by physicians without judicial or institutional review. Further research and debate are needed to develop optimal decision-making strategies for these difficult cases.
许多重症监护病房(ICU)医生曾对缺乏决策能力且没有替代决策者的患者撤除生命支持,但对于这些患者的决策实践知之甚少。我们试图确定这类患者入住大城市医院ICU的频率以及针对他们如何做出临终决策。
前瞻性观察队列研究。
2003年至2004年7个月期间连续入住西海岸一家大城市医院内科ICU的成年患者。
主治医生针对每位他们考虑对其限制生命支持、缺乏决策能力且没有法定认可替代决策者的患者,填写一份关于决策过程的问卷。
在研究期间收治的303例患者中,49例(16%;95%置信区间[CI],12 - 21%)在整个ICU住院期间缺乏决策能力且没有替代者。与所有其他ICU患者相比,这些患者更可能为男性(88%对69%;p = 0.002)、白人(42%对23%;p = 0.028)以及年龄≥65岁(29%对13%;p = 0.007)。医生考虑对49例既缺乏决策能力又没有替代决策者的患者中的37%(18例)停止或撤除治疗。对于这18例患者中的56%(10例),征求了另一位主治医生的意见;对于33%(18例中的6例),ICU团队独立做出决策,对于11%(18例中的2例),获取了法院或医院伦理委员会的意见。总体而言,研究期间27%(49例中的13例)的死亡患者是缺乏替代者的无行为能力患者(95%CI,15 - 41%)。
该医院内科ICU收治的患者中有16%既缺乏决策能力又没有替代决策者。限制生命支持的决策通常由医生做出,未经司法或机构审查。需要进一步研究和辩论,以制定针对这些疑难病例的最佳决策策略。